SRPT

13.3305.93%
DS

Douglas S. Ingram

Advisor

Mr. Douglas S. Ingram, J.D., Esq., also known as Doug, served as Independent Director of Arrowhead Pharmaceuticals, Inc. since February 06, 2025 until March 20, 2026. He had been Chief Executive Officer Sarepta Therapeutics, Inc. since June 26, 2017 until July 28, 2026 and served as its President since June 26, 2017. Mr. Ingram serves as an Independent Director of Relay Therapeutics, Inc., since June 2019. He serves as Special Advisor on the executive leadership team at Actavis. Mr. Ingram served as the Chief Executive Officer and President at Chase Pharmaceuticals Corporation, Inc. since December 2, 2015 until November 2016. Mr. Ingram served as the President of Allergan, Inc. from July 2013 to March 2015. He served as the President of Europe, Africa, Middle East and Executive Vice President at Allergan, Inc from August 1, 2010 to June 24, 2013. Mr. Ingram served as the Chief Administrative Officer of Allergan Inc., from October 2006 to August 1, 2010 and Chief Ethics Officer from July 2001 to August 1, 2010, Executive Vice President from October 2003 to August 1, 2010 and its General Counsel January 2001 to June 2009. He was Secretary at Allergan Inc., from October 2003 to August 1, 2010. He served as the Corporate Vice President of Allergan Inc. since July 2001. Mr. Ingram served as General Counsel and Secretary of Allergan Specialty Therapeutics Inc. since October 1998. He served as Allergan’s General Secretary from July 2001 to July 2010. He served as Allergan’s Assistant Secretary since November 1998. He served as Allergan Inc.’s Associate General Counsel since August 1998, Assistant General Counsel since January 1998 and Senior Attorney and Chief Litigation Counsel of Allergan since March 1996, when he first joined Allergan Inc. Mr. Ingram has more than two decades of executive leadership experience in the life sciences. He was responsible for building and leading numerous aspects of the global organization including Regulatory Affairs and Pharmacovigilance, Legal Affairs, Information Technology, Public Relations and External Communication, Human Resources, Audit and Compliance. He served as an Attorney with the law firm of Gibson, Dunn & Crutcher LLP from August 1988 to March 1996. He served as Vice Chairman and Director of Nemus Bioscience Inc. since June 1, 2015 until January 18, 2018. He had been a Director at Sarepta Therapeutics, Inc. since June 28, 2017 until July 28, 2026 and will serve the company in an advisory capacity until the end of 2026. He served as a Director of Endo International plc since May 5, 2016. He is a Director at Emerald Bioscience, Inc. Mr. Ingram has been a Director of Volcom Australia Pty Ltd. since June 2005 and served as Director of Pacific Mutual Holding Company since May 1, 2015 until May 2018. He served as an Independent Director of Volcom, Inc., from June 2005 to June 17, 2011 and served as its Lead Independent Director from June 2008 to June 17, 2011. He serves as the Director of Pacific Life insurance Company. He was a Director at Chase Pharmaceuticals Corporation, Inc. since December 2, 2015. He served as a Trustee of Suburban Hospital, Inc. He served as a Director of ECC Capital Corp., from January 2005 to March 1, 2007. He serves on the Board of United Cerebral Palsy of Orange County. Mr. Ingram received a BS degree in 1985 from Arizona State University. He received his Juris Doctorate from University of Arizona in 1988.

Positions